| Species : |
Human |
| Source : |
Mammalian Cells |
| Tag : |
His |
| Protein Length : |
35-425 a.a. |
| Description : |
Human LRRTM1 is a58-59 kDa type I transmembrane protein that belongs to the LRRTM family ofproteins within the leucine-rich repeat superfamily. It is synthesized as aprecursor with a 34 amino acid signal sequence, a 393 aa luminal region, a 21aa transmembrane region, and a 74 aa cytoplasmic region. The luminal portionof LRRTM1 contains three N-linked glycosylation sites and 10 LRRs flanked bycysteine-rich domains. The cytoplasmic region contains several tyrosine,serine, and threonine residues that have potential to be phosphorylated andthus to be involved in signal transduction. |
| Form : |
Lyophilized from a0.2 μm filtered solution in PBS. |
| N-terminalSequence : |
Ala35 |
| Molecular Weight : |
44.4 kDa |
| Activity : |
Measuredby its ability to enhance neurite outgrowth of E18 rat embryonic corticalneurons. Able to significantly enhance neurite outgrowth when immobilized at6-25 μg/mL on a nitrocellulose-coated microplate. |
| Endotoxin Level : |
<1.0 EUper 1 μg of the protein by the LAL method. |
| SDS-PAGE : |
70-85kDa, reducing conditions. |
| Purity : |
>95%,by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Reconstitution : |
100μg/mL in sterile PBS |
| Storage : |
Use amanual defrost freezer and avoid repeated freeze-thaw cycles. 12 months fromdate of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterileconditions after reconstitution. 3 months, -20 to -70°C under sterileconditions after reconstitution. |